Effects of Rhythmic Auditory Stimulation on Gait and Motor Function in Parkinson's Disease: A Systematic Review and Meta-Analysis of Clinical Randomized Controlled Studies

• Published in: Frontiers in neurology 2022-04, Vol.13, p.818559-818559
• Main Authors: Wang, Lei, Peng, Jin-Lin, Ou-Yang, Jian-Bin, Gan, Li, Zeng, Shuai, Wang, Hong-Yan, Zuo, Guan-Chao, Qiu, Ling
• Format: Article
• Language: English
• Subjects: meta-analysis; Neurology; Parkinson's; parkinsonism; RAS; rhythmic auditory stimulation
• ISSN: 1664-2295; 1664-2295
• DOI: 10.3389/fneur.2022.818559

This study aimed to summarize the effectiveness of rhythmic auditory stimulation (RAS) for the treatment of gait and motor function in Parkinson's disease (PD) through a systematic review and meta-analysis. All studies were retrieved from eight databases. The effects of RAS on PD were determined using the following indicators: gait parameters including step length, stride width, step cadence, velocity, stride length; motor function including 6 min walk test (6MWT) and timed up-and-go test (TUGT); the Unified Parkinson's Disease Rating Scale (UPDRS); and the Berg Balance Scale (BBS). The risk map of bias of the quality of the studies and the meta-analysis results of the indicators was prepared with RevMan 5.2 software. Twenty-one studies were included in the systematic review, and 14 studies were included in the meta-analysis. In the meta-analysis, the results of gait parameters, namely, velocity, step length, and stride length, were statistically significant ( < 0.05), whereas the results of cadence and stride width were not statistically significant ( ≧ 0.05). The results of 6MWT and TUGT for motor function as well as UPDRS-II, UPDRS-III, and BBS were statistically significant ( < 0.05). RAS could improve gait parameters, walking function, balance function, and daily living activities of individuals with PD. The application of RAS in conventional rehabilitation approaches can enhance motor performance in PD. Future studies should use a large sample size and a rigorous design to obtain strong conclusions about the advantages of RAS for the treatment of gait and motor function in PD.